IM Cannabis

At a composite of 38, IM Cannabis Corp. scores as Neutral, with conviction of 3 out of 5 backing the assessment. Four pillars feed the composite in fixed weights (35/25/25/15 for fundamentals, regulatory, market, and editorial), and no clause of the score is hidden from the reader. Regulatory carries this profile, printing 56 and setting the ceiling on the composite. The fundamentals pillar sits at 26, and is the main drag on the composite.

Working through the numbers, IM Cannabis Corp. shows reported revenue growth of -30.6 percent year over year, an operating margin of -19.3 percent, gross margin of 15.0 percent, a market cap near 1 million, a filing cadence of 2 regulator events in the trailing 90 days, a jurisdictional posture reading of 50. Those inputs are the ones that drive the Neutral anchor rather than sentiment. The scoring pipeline pulls only from primary regulatory filings, licensed fundamentals data, institutional pricing feeds, and CIN newsroom coverage, and each pillar exposes its own inputs. This lets IM Cannabis Corp. be lined up against the US operator peer set on identical inputs, with refresh cadence tied directly to primary-source ingest.

Filing cadence and jurisdictional posture remain the primary drivers, with regulatory contributing 56. A sustained lift in filing frequency across the trailing 90 days combined with zero enforcement events would tighten the Neutral conclusion.